Thibault J Harmand

6PUBLICATIONS
13CO-AUTHORS
GlycoconjugatesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsHaematologyEnzymes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 03, 2025
A multivalent nanobody-drug conjugate to prevent and treat influenza virus infections.

Thibault J Harmand, Laura Pietrok, Helen Rich

|Aug 19, 2021
Converting an Anti-Mouse CD4 Monoclonal Antibody into an scFv Positron Emission Tomography Imaging Agent for Longitudinal Monitoring of CD4+ T Cells.

Ashraful Islam, Novalia Pishesha, Thibault J Harmand

|Jul 02, 2021
Nanobodies as in vivo, non-invasive, imaging agents.

Thibault J Harmand, Ashraful Islam, Novalia Pishesha

|Jun 15, 2021
Asparaginyl Ligase-Catalyzed One-Step Cell Surface Modification of Red Blood Cells.

Thibault J Harmand, Novalia Pishesha, Fabian B H Rehm

|Oct 02, 2019
Site-Specific Sequential Protein Labeling Catalyzed by a Single Recombinant Ligase.

Fabian B H Rehm, Thibault J Harmand, Kuok Yap

|Sep 21, 2018
One-Pot Dual Labeling of IgG 1 and Preparation of C-to-C Fusion Proteins Through a Combination of Sortase A and Butelase 1.

Thibault J Harmand, Djenet Bousbaine, Alix Chan

Pageof 1